Opinion|Videos|July 29, 2024
Beyond EHA 2024: Promising Research in Multiple Myeloma to Watch
Author(s)Joseph Mikhael, MD
Dr. Mikhael discusses EHA 2024 data he found particularly noteworthy to share with colleagues.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- Please discuss any other data in multiple myeloma released at EHA 2024 that you find noteworthy to share with colleagues.
- Outside of EHA 2024 what ongoing research efforts are you most excited for in the treatment and management of multiple myeloma?
- What can we look forward to through the end of the year and beyond?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial
4
Contextualizing Golcadomide's Efficacy Signal in the RRFL Landscape
5